| Code | 3836E | ||||||||||
| MA number | 64/0155/23-S | ||||||||||
| Product Form: | int opo1x7,5 ml/375 µg (fľ.HDPE) | ||||||||||
| MA Status: | R - Valid Marketing Authorisation | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | Zaklady Farmaceutyczne POLPHARMA S.A., Poland | ||||||||||
| Therapeutic Class: | 64 - OPHTHALMOLOGICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 24 | ||||||||||
| Container: | bottle HDPE | ||||||||||
| Route of admin.: | Ocular use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(3) hybrid application |
| MA issued: | 21.11.2023 |
| Validity: | 21.11.2028 |
| Pediatric indication: | Yes |
| Pediatric posology: | Yes |
| Pediatric warnings: | Yes |
| SPC: |
SPC_Latanoprost Polpharma_10 2023.pdf
|
| PIL: |
PIL_Latanoprost Polpharma_10 2023.pdf
|
| Safety feature | Yes |
| Data update: | 22.11.2023 |
